Verve Therapeutics Ratios and Metrics

Market cap in millions PHP. Fiscal year is January - December.

Millions PHP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jul '25 Jul 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Market Capitalization	973	1,250	1,225	3,510	9,750	2,875	Upgrade
Market Cap Growth	-15.18%	2.04%	-65.10%	-64.00%	239.13%	57.10%	Upgrade
Enterprise Value	946	1,217	1,365	3,668	9,717	2,846	Upgrade
Last Close Price	3.89	5.00	4.90	14.04	39.00	11.50	Upgrade
PB Ratio	16.53	20.08	-10.88	-57.57	763.14	54.28	Upgrade
P/TBV Ratio	15.18	18.57	-	-	560.14	52.09	Upgrade
Debt / Equity Ratio	-	-	-1.38	-2.08	-	0.52	Upgrade
Quick Ratio	0.26	0.32	0.03	0.06	0.35	0.66	Upgrade
Current Ratio	0.28	0.34	0.03	0.06	0.35	0.66	Upgrade
Return on Equity (ROE)	-	-	-	-	-122.27%	-23.56%	Upgrade
Return on Assets (ROA)	-6.19%	-5.55%	-5.93%	-14.26%	-11.90%	-8.29%	Upgrade
Return on Capital (ROIC)	-19.22%	-15.49%	-17.73%	-47.36%	-22.26%	-10.44%	Upgrade
Earnings Yield	-2.39%	-2.57%	-4.21%	-2.11%	-0.39%	-0.41%	Upgrade
FCF Yield	-	-2.09%	-1.46%	-0.63%	-0.17%	-0.69%	Upgrade

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.